688513.SH
苑东生物
SSE · Healthcare · Biotechnology · CN
CNY 42.91
−5.82%Margins
Gross margin
74.9%
EBITDA margin
30.2%
EBIT margin
22.2%
Net margin
20.3%
FCF margin
16.3%
9.2%
Return on equity
7.3%
Return on assets
9.8%
Return on invested capital
0.36x
Asset turnover
CNY 311.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026